RISK FACTOR PREVALENCE AND PROBABILITY OF FATAL CARDIOVASCULAR EVENTS IN MEN 42-44 YEARS OLD

Abstract

Aim. To evaluate prevalence of the main risk factors (RF) and fatal outcome probability of cardiovascular diseases (CVD) in 10 years among men 42-44 years old. Material and methods. Totally, 303 men studied at the age 42-44 y.o., under the ordinary step of 32-year lasting prospective cohort study. Response on invitation for investigation was 30,1%. Subjects underwent standardized questionnaire; triple blood pressure measurement, as pulse, length and mass of body; thickness of adipose layers over triceps, scapula and abdominal wall measurement; waist and hip circumference; measurement of total and high density lipoproteides cholesterol, as triglycerides and blood glucose. Statistics was done via software IBM SPSS Statistics 22. Results. The characteristics of the studied group is presented as simple descriptive statistics. At the moment of study, 23% of men had elevated blood pressure, mostly at the level of arterial hypertension (AH) grade 1 (14,5%). There was anamnesis of AH in 44,6% participants and 27,1% take antihypertensive medication, but just 8,9% do treat actively. Overweight and obesity were found in 67% of the studied. Abdominal obesity was found in 87 (28,7%). More than 40% of them smoke. In 42,6% of men there were significant proatherogenic changes in serum found. Low physical activity was set for 26,1% of the studied. 65% of men from this group have 2 and more risk factors. It is stated that most of the men (90%) have moderate risk of fatal CVD development next 10 years, by SCORE, and just 8,9% have low estimated risk. The main impact on the overall risk have cholesterol (47,6%) and smoking (33,7%). Conclusion. High rate of the main RF for CVD in men 42-44 y.o. and moderate probability of fatal CVD for the next 10 years strictly dictate on the necessity of individualized active prevention of CVD with the main direction towards positive motivation for healthy life style — cessation of bad habits, especially smoking, rational food intake, physical activity optimization, atherogenic lipid profile correction and effective AH treatment.